Success Of German Cost-Control Law Raises Prospect Of Further Cuts For Pharma

Germany's 2011 pharmaceutical prescribing report shows that the cost control law (AMNOG) is fulfilling its purpose, prompting insurers to call for even further pressure on the industry to reduce costs.